Sr. Vice President Genzum Life Sciences San Diego, California
Amidst global health crises, such as the recent COVID-19 pandemic, rapid development of vaccines and access across the globe is critical to have an impact on Global Health. • Long lead times for development and manufacturing • Vaccines typically require cold-chain storage which prevents a stockpiling approach. • Access in Low- and Middle-Income Countries/remote settings where distribution networks and health care infrastructure are not readily available for appropriate distribution, storage, and vaccination. • Needle phobia which prevents individuals from vaccination even in developed countries We will explore the role of nasal delivery systems, microneedle technology, mRNA technology, viral vector-based technology on overcoming these challenges. The aim is to foster active discussion on the advances in drug delivery technologies and their applications for rapid development of safe and effective vaccines, that can be distributed across the globe to ensure the world responds to future pandemics/epidemics in a swift and efficient manner.
Learning Objectives:
Evaluate the impact of drug delivery platforms; nasal delivery, microneedle technology, mRNA technology,and viral vector-based technology on addressing vaccine development, storage, distribution challengesduring global health crises like pandemics.
Analyze the role of innovative drug delivery technologies in enhancing vaccine stability, safety, and efficacy, with a focus on overcoming challenges like long development lead times, cold-chain storage requirements, and limited access in low- and middle-income countries (LMICs) and remote settings.
Formulate strategies to leverage emerging drug delivery technologies for rapid vaccine development, manufacturing, and equitable global distribution, contributing to improved pandemic preparedness and response efforts.
